Archive: 11/02/2014

New target isolated for leukemia drug development

There are potentially effective treatments for acute myeloid leukemia (AML), but they only work in 20 to 40 percent of cases. In a paper published today in Leukemia, a Nature journal, a UT Health Science Center researcher ...

page 5 from 10